McKesson agrees on Option Care investment. McKesson stock trades at EUR 887.20
Published on 10/24/2026 at 10:18 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWSMcKesson commits to infusion care
- On October 6, 2026, McKesson agreed to invest approximately USD 1.4 billion for a minority interest in Option Care Health.
- McKesson stock traded at EUR 887.20 in weekend trading at Lang & Schwarz at 10:12 a.m. CEST on October 24, 2026.
- The next Xetra session is scheduled for October 26, 2026.
On October 6, 2026, McKesson Corporation agreed with CD&R and Option Care Health to acquire Option Care Health. McKesson will invest approximately USD 1.4 billion for a minority interest of approximately 49%, while CD&R will hold approximately 51%. The transaction is expected to close in the first half of calendar year 2027, subject to customary closing conditions, including shareholder and regulatory approvals, according to McKesson.
At 10:12 a.m. CEST on October 24, 2026, McKesson stock traded in weekend trading at Lang & Schwarz at EUR 887.20. The quoted bid was EUR 885.40 and the ask was EUR 889.00.
Weekend trading at Lang & Schwarz
The company’s euro price was EUR 887.20 at the recorded time. The further course of weekend trading at Lang & Schwarz until 1:00 p.m. CET/CEST is shown by the continuously updated real-time quote of McKesson stock.
The Option Care agreement
Option Care Health will remain a separate company led by its own management team. Following completion, McKesson intends to account for its minority interest using the equity method. The agreement provides for Option Care Health to become privately held and no longer publicly listed after closing, subject to the stated conditions.
Market context: Market report S&P 500.
Next Xetra session
The next Xetra session is scheduled for October 26, 2026. The transaction announcement remains dated October 6, 2026, while the Lang & Schwarz quote is dated October 24, 2026.
